Results 31 to 40 of about 6,304 (197)

Urban-rural differences in seasonal malaria chemoprevention coverage and characteristics of target populations in nine states of Nigeria: a comparative cross-sectional study. [PDF]

Malar J
Background Differences between urban and rural contexts in terms of sociodemographic characteristics, geographical features and risk perceptions may lead to disparities in coverage and related outcomes of community-based preventive interventions, such as
Ibinaiye T, Rotimi K, Balogun A, Aidenagbon A, Oguoma C, Baker K, Ogunmola O, Oresanya O, Rassi C, Nnaji C.   +9 more
europepmc   +2 more sources

Trend of N86Y and Y184F Mutations in Pfmdr1 Gene in Children Under Seasonal Malaria Chemoprevention Coverage in Nanoro, Burkina Faso. [PDF]

Acta Parasitol
Background Seasonal malaria chemoprevention (SMC) is an effective malaria preventive intervention in sub-Sahara Africa. However, as with any other drug-based intervention, the large-scale deployment of this strategy could lead to Amodiaquine plus ...
Millogo KS, Kaboré B, Sondo P, Compaoré EW, Kouevi AFC, Kambou SAE, Rouamba T, Kazienga A, Ilboudo H, Tahita MC, Bouda I, Derra K, Bamba S, Tinto H.   +13 more
europepmc   +2 more sources

Evolution of Pfdhps and Pfdhfr mutations before and after adopting seasonal malaria chemoprevention in Nanoro, Burkina Faso. [PDF]

Sci Rep
Seasonal Malaria Chemoprevention consisting of monthly administration of amodiaquine/sulfadoxine-pyrimethamine to children aged 3–59 months during the transmission season could promote SP-resistance.
Bohissou FET, Sondo P, Inoue J, Rouamba T, Kaboré B, Nassa GJW, Kambou AES, Traoré TE, Asua V, Borrmann S, Tinto H, Held J.   +11 more
europepmc   +2 more sources

Predictors of accessing seasonal malaria chemoprevention medicines through non-door-to-door distribution in Nigeria [PDF]

Malar J
Background In Nigeria, seasonal malaria chemoprevention (SMC) is typically administered door-to-door to children under five by community medicine distributors during high transmission seasons. While door-to-door distribution (DDD) is exclusively employed
Huang S, Baker K, Ibinaiye T, Oresanya O, Nnaji C, Richardson S.   +5 more
europepmc   +2 more sources

A quasi-experimental study to estimate effectiveness of seasonal malaria chemoprevention in Aweil South County in Northern Bahr El Ghazal, South Sudan. [PDF]

Malar J
Background Seasonal malaria chemoprevention (SMC) is an effective intervention to prevent malaria in children in locations where the burden of malaria is high and transmission is seasonal.
Khan J, Suau Sans M, Okot F, Rom Ayuiel A, Magoola J, Rassi C, Huang S, Mubiru D, Bonnington C, Baker K, Ahmed J, Nnaji C, Richardson S.   +12 more
europepmc   +2 more sources

Examination of factors impacting spitting or vomiting among children under 5 years of age during seasonal malaria chemoprevention: a quantitative study in Burkina Faso, Chad, Nigeria and Togo. [PDF]

Trop Med Health
Background Since 2012, the World Health Organization has recommended seasonal malaria chemoprevention (SMC) with sulfadoxine-pyrimethamine plus amodiaquine (SPAQ) for children aged 3–⁠59 months in regions where malaria transmission is seasonal.
Gao C, Huang S, Ibinaiye T, Sawadogo B, Traore A, Compaoré CS, Awokou F, Nnaji CA, Baker K, Wang D, Richardson S.   +10 more
europepmc   +2 more sources

Facilitators and barriers to seasonal malaria chemoprevention (SMC) uptake in Nigeria: a qualitative approach

Malaria Journal, 2023
Background SMC was adopted in Nigeria in 2014 and by 2021 was being implemented in 18 states, over four months between June and October by 143000 community drug distributors (CDDs) to a target population of 23million children. Further expansion of SMC is
N. Ogbulafor, P. Uhomoibhi, E. Shekarau, J. Nikau, C. Okoronkwo, N. Fanou, I. Mbaye, J. Ndiaye, Andre-Marie Tchouatieu, Abena Poku-Awuku, C. Merle, S. Scott, P. Milligan, Aminu Ali, Hauwa’u Evelyn Yusuf, S. Oguche, T. Dahiru   +16 more
semanticscholar   +4 more sources

The monthly trends of malaria cases in children under 5 years of age in Guinea: comparative analysis between a seasonal malaria chemoprevention (SMC) and a non-SMC health district. [PDF]

Malar J
Background The Republic of Guinea, where malaria represents the leading cause of morbidity and mortality among children, the seasonal malaria chemoprevention (SMC) is deployed only in areas with very seasonal modes of transmission.
Keita KS, Camara BS, Camara S, Barry F, Sidibe T, Kourouma K, Diallo R, Toure M, Camara A, Balde MD.   +9 more
europepmc   +2 more sources

Awareness, knowledge, attitude, and practice of adverse drug reaction reporting among health workers in primary health centres participating in seasonal malaria chemoprevention campaign in Nigeria in 2022: a cross-sectional survey. [PDF]

BMC Health Serv Res
Background Evaluating health workers’ knowledge and practice of adverse drug reaction (ADR) reporting is an important step in identifying gaps in quality ADR reporting during public health interventions like the seasonal malaria chemoprevention (SMC ...
Rotimi K, Fagbemi B, Omole G, Biambo AA, Ibinaiye T, Iwegbu A, Ogunmola O, Oguoma C, Oresanya O.   +8 more
europepmc   +2 more sources

Effect of seasonal malaria chemoprevention on the acquisition of antibodies to Plasmodium falciparum antigens in Ouelessebougou, Mali [PDF]

Malaria Journal, 2017
Background Seasonal malaria chemoprevention (SMC) is a new strategy to reduce malaria burden in young children in Sahelian countries. It consists of the administration of full treatment courses of sulfadoxine–pyrimethamine plus amodiaquine to children at
Almahamoudou Mahamar, Djibrilla Issiaka, Amadou Barry, Oumar Attaher, Adama B. Dembele, Tiangoua Traore, Adama Sissoko, Sekouba Keita, Bacary Soumana Diarra, David L. Narum, Patrick E. Duffy, Alassane Dicko, Michal Fried   +12 more
doaj   +3 more sources